UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weekly docetaxel in the treatment of metastatic breast cancer

Therapeutics and clinical risk management, 2008-10, Vol.4 (5), p.1047-1059

2008

Volltextzugriff (PDF)

News on the medical treatment of young women with early-stage HER2-negative breast cancer

Expert opinion on pharmacotherapy, 2016-08, Vol.17 (12), p.1643-1655

2016

Volltextzugriff (PDF)

New dosimetric parameters to predict ano-rectal toxicity during radiotherapy treatment

Physica medica, 2022-07, Vol.99, p.55-60

2022

Volltextzugriff (PDF)

Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): Results of a multicentric Italian observational study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13053-e13053

2018

Volltextzugriff (PDF)

Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients

Expert review of clinical pharmacology, 2016-09, Vol.9 (9), p.1153-1161

2016

Volltextzugriff (PDF)

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study

Oncotarget, 2017-07, Vol.8 (27), p.44800-44810

2017

Volltextzugriff (PDF)

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian multicenter, randomized, phase II study

Cancer, 2006-12, Vol.107 (12), p.2898-2905

2006

Volltextzugriff (PDF)

A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer

Medical oncology (Northwood, London, England), 2013-06, Vol.30 (2), p.533, Article 533

2013

Volltextzugriff (PDF)

Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma

Annals of the New York Academy of Sciences, 2006-11, Vol.1089 (1), p.98-103

2006

Volltextzugriff (PDF)

Cytokine Gene Polymorphisms and Breast Cancer Susceptibility

Annals of the New York Academy of Sciences, 2006-11, Vol.1089 (1), p.104-109

2006

Volltextzugriff (PDF)

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site

Cancer, 2006-12, Vol.107 (12), p.2898-2905

2006

Volltextzugriff (PDF)

Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report

Anticancer research, 2002-03, Vol.22 (2B), p.1183

2002

Volltextzugriff (PDF)

Weekly Administration of Gemcitabine Plus Docetaxel in Patients with Advanced Breast Cancer: A Phase 1 Study

Oncology, 2002-01, Vol.62 (1), p.33-38

2002

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Weekly docetaxel in the treatment of metastatic breast cancer

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study

News on the medical treatment of young women with early-stage HER2-negative breast cancer

New dosimetric parameters to predict ano-rectal toxicity during radiotherapy treatment

Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): Results of a multicentric Italian observational study

Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian multicenter, randomized, phase II study

A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer

Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma

Cytokine Gene Polymorphisms and Breast Cancer Susceptibility

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site

Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report

Weekly Administration of Gemcitabine Plus Docetaxel in Patients with Advanced Breast Cancer: A Phase 1 Study

Suchergebnisse filtern